Aggregated price index with volume information
Summary:
- Drugstore Chains stocks up 1.8% on average while median return up 2.7% in a day
- Drugstore Chains stocks up 2.9% on average while median return up 6.1% in a week
- Drugstore Chains stocks down 4.5% on average while median return down 1.0% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $YI 10.6%, $CVS 0.6%
- 1M losers are : Losers for past month are $BIMI -11.2%, $WBA -24.5%
- 1W winners are : Winners for past week are $YI 9.6%, $WBA 7.4%
- 1W losers are : Losers for past week are $BIMI -10.6%
Correlation Analysis
Index correlation analysis
Correlation for the past month is 12.6%, for the past 3 months is 13.8%
In the past month for a 5 days rolling window, the highest corrrelation is 47.6%, the lowest correlation is -20.8%, the latest correlation is 5.5%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 57.8% between CVS and WBA
The lowest correlation is -24.4% between BIMI and WBA
Bears control the S 500 now. Plus: This small stock trades like it could have big news.
(Bloomberg) -- JPMorgan Chase & Co. is sounding out investors on a potential high-yield bond sale by Walgreens Boots Alliance Inc. to address the recently downgraded drug-store chain’s near-term debt maturities, according to people familiar with the matter. Most Read from BloombergTrump Risks Losing Voters He Needs With Loaded Attacks on HarrisHarris Just Showed Why Trump Is So Afraid of HerMarkets Tear Up Popular Trades That Reached ‘Stupid Levels’Stocks Caught in Tug of War Between Tech and Re
Insurers with a focus on Medicaid are seeing higher costs per member after millions of enrollees were forced out of the plans.
These stocks could be enticing to income and value investors, but they're both risky bets that aren't for the faint of heart.
Q2 2024 Agree Realty Corp Earnings Call
Will the company take the necessary steps to stop the stock's free fall?
Top executives of CVS Caremark, Optum Rx and Express Scripts made a rare congressional appearance to defend pharmacy benefit managers’ drug pricing policies.
Findings from the House Oversight investigation add to criticism that pharmacy-benefit managers are driving up drug spending.
DEERFIELD, Ill., July 23, 2024--Walgreens today announced it received a project award valued up to $25 million through the Rapid Response Partnership Vehicle (RRPV) to conduct a Phase IV observational clinical study focused on assessing Correlates of Protection (CoP), known as responses to a vaccine that predict how well a vaccinated person will be protected from future infections, using COVID-19 vaccine data. The RRPV is a Consortium funded by the Biomedical Advanced Research and Development Au
Find out if the huge yields these pressured dividend payers offer could be worth the risk.